Fundraising Fox

Jim Plante

Investor

Founder at Thynk Capital

United States

About

Entrepreneur, inventor and investor with over 30 years of experience in technology, healthcare and biotechnology, and nearly 20 years investing in early-stage tech and life science companies. He founded Klotho Therapeutics, Pathway Genomics, E-Band Communications and SmartDrive Systems, led the turnaround of Beltronics, and served on the U.S. Industry Trade Advisory Committee (2015-2018).

Experience

  1. IMX DataFounder and CEOcurrent2024 β€” present
  2. Thynk CapitalManaging Partner and Foundercurrent2011 β€” present
  3. Klotho Therapeutics, Inc.CEO and Foundercurrent2017 β€” present
  4. Various CompaniesInventorcurrent1985 β€” present
  5. TIGER 21Founding Member, Las Vegas Chaptercurrent2019 β€” present
  6. Foundation for Kidney Transplant ResearchFoundercurrent2014 β€” present
  7. IVIVA Medical IncVenture Investorcurrent2021 β€” present
  8. Plante CapitalFoundercurrent2001 β€” presentSan Diego, CA
  9. Intelligent Medicine Exchange (IMX)CEO and Founder2021 β€” 2026
  10. Pathway Genomics CorporationFounder, CEO and Seed Investor2008 β€” 2017San Diego
  11. SmartDrive Systems, IncFounder, CEO and Seed Investor2004 β€” 2008San Diego, CA
  12. E-Band Communications, LLCCo-Founder, CEO and Seed Investor2002 β€” 2004
  13. Maxima Technologies (Quantum Laser Communications)Founder and CEO1999 β€” 2003
  14. Bel-TronicsPresident1996 β€” 1997
  15. Illinois Air National GuardMilitary Service1985 β€” 1991

Education

  1. Southern Illinois University, CarbondaleBachelor of Science, Electrical and Electronics Engineering1986 β€” 1990

Skills & more

SaaS9Enterprise Software8Entrepreneurship99Start-ups89Venture Capital55Biotechnology33Product Management30Business Development30Business Strategy25Analytics20Product Development19Mergers & Acquisitions18
+12 moreProduct MarketingCompetitive AnalysisProduct LaunchE-commerceLife SciencesCorporate DevelopmentProgram ManagementBusiness PlanningCapital MarketsMarketing StrategyLeadershipStrategy

From Jim's professional profile.

Deals Β· 17

ElevianSolo GP

via Thynk Capital Β· filed Jul 2020

WinSanTorSolo GP

via Thynk Capital Β· filed May 2017

TheragenepharmaSolo GP

via Thynk Capital Β· filed Jul 2015

ImxhealthSolo GP

via Thynk Capital

Iviva MedicalSolo GP

via Thynk Capital

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Frequently asked questions

Where does Jim Plante work?
Jim Plante is Founder at Thynk Capital.

Founder mafias

Same school

Shared employers